Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: Simulations Plus (SLP), Stryker (SYK)

Tipranks - Sat Apr 11, 6:50AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Simulations Plus (SLP) and Stryker (SYK) with bullish sentiments.

Easter Sale - 70% Off TipRanks

Simulations Plus (SLP)

In a report released today, Max Smock from William Blair reiterated a Buy rating on Simulations Plus. The company’s shares closed last Thursday at $12.99.

According to TipRanks.com, Smock ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -22.4% and a 10.0% success rate. Smock covers the Healthcare sector, focusing on stocks such as Fortrea Holdings Inc., Lifecore Biomedical, and Charles River Labs. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Simulations Plus with a $16.00 average price target, representing a 25.0% upside. In a report issued on April 2, Craig-Hallum also maintained a Buy rating on the stock.

See the top stocks recommended by analysts >>

Stryker (SYK)

In a report released today, Matthew O’Brien from Piper Sandler reiterated a Buy rating on Stryker, with a price target of $420.00. The company’s shares closed last Thursday at $339.14.

According to TipRanks.com, O’Brien is ranked 0 out of 5 stars with an average return of -7.9% and a 35.3% success rate. O’Brien covers the Healthcare sector, focusing on stocks such as Kestra Medical Technologies Ltd., Shoulder Innovations, Inc., and Tandem Diabetes Care. ;'>

Stryker has an analyst consensus of Strong Buy, with a price target consensus of $426.68, representing a 26.2% upside. In a report issued on April 6, Evercore ISI also maintained a Buy rating on the stock with a $365.00 price target.

Read More on SLP:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.